Advertisement
Insmed Incorporated

Insmed Incorporated (INSM) Stock Overview

Explore Insmed Incorporated’s financial performance, market position, analyst ratings, and future outlook.

INSMNASDAQ
HealthcareBiotechnology
$97.51
$3.34(3.55%)
U.S. Market is Open · 14:08
Advertisement

Insmed Incorporated (INSM)

Meyka AI Score

Z

Key Financials

Market Cap21.5B
P/E Ratio-16.72
EPS (TTM)$-5.76
ROE-1.30%
Fundamental Analysis

AI Price Forecasts

1 MonthN/A
3 MonthsN/A
1 Year TargetN/A

INSM Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Insmed Incorporated (INSM) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of F, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 30.26, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of N/A.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -16.72 and a market capitalization of 21.5B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
-7.23%
5-Day Change
-11.47%
1-Month Change
-9.34%
3-Month Change
-36.13%
6-Month Change
-51.60%
Year-to-Date (YTD) Change
-47.21%
1-Year Change
1.04%
3-Year Change
371.18%
5-Year Change
216.06%
All-Time (Max) Change
-44.32%

Contact Information

908 977 9900
700 US Highway 202/206, Bridgewater, NJ, 08807

Company Facts

12,710 Employees
IPO DateJun 1, 2000
CountryUS
Actively Trading

Frequently Asked Questions